Mentor: Jon Stavres, Ph.D.

This study examines the impact of glucagon-like peptide-1 (GLP-1) receptor agonist medications on physical activity patterns, health behaviors, and motivational factors among adults. While GLP-1 medications are widely used for glycemic control and weight loss, their influence on long-term behavioral changes remains unclear. Using a cross-sectional survey design, this study compares individuals currently using GLP-1 medications with non-users to assess differences in physical activity levels, lifestyle habits, and health-related motivation. Data will be collected from a large, diverse adult sample across the United States via an anonymous online survey. Findings from this study aim to identify whether reliance on GLP-1 medications influences engagement in health-promoting behaviors and to inform clinical strategies that integrate pharmacological and behavioral interventions for improved cardiometabolic outcomes.

Explore the Project